PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 108 filers reported holding PULMONX CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $621,907 | -21.2% | 60,204 | 0.0% | 2.98% | -79.2% |
| Q2 2023 | $789,274 | +17.3% | 60,204 | 0.0% | 14.32% | +34.9% |
| Q1 2023 | $673,081 | +32.6% | 60,204 | 0.0% | 10.62% | +29.4% |
| Q4 2022 | $507,520 | -49.4% | 60,204 | 0.0% | 8.20% | +31.0% |
| Q3 2022 | $1,003,000 | +13.2% | 60,204 | 0.0% | 6.26% | +100.3% |
| Q2 2022 | $886,000 | -40.7% | 60,204 | 0.0% | 3.13% | -74.2% |
| Q1 2022 | $1,494,000 | -22.6% | 60,204 | 0.0% | 12.13% | -53.7% |
| Q4 2021 | $1,931,000 | -42.8% | 60,204 | -35.8% | 26.20% | +14.2% |
| Q3 2021 | $3,376,000 | -18.5% | 93,831 | 0.0% | 22.93% | +186.6% |
| Q2 2021 | $4,140,000 | -88.9% | 93,831 | -88.5% | 8.00% | -80.3% |
| Q1 2021 | $37,279,000 | -33.7% | 815,019 | 0.0% | 40.66% | -17.1% |
| Q4 2020 | $56,253,000 | – | 815,019 | – | 49.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XIII Associates, LLC | 994,971 | $10,278,050 | 5.54% |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $621,907 | 2.98% |
| PURA VIDA INVESTMENTS, LLC | 726,298 | $7,502,658 | 1.42% |
| CFM WEALTH PARTNERS LLC | 264,039 | $2,727,523 | 0.71% |
| BRAIDWELL LP | 988,559 | $10,211,814 | 0.32% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,017,958 | $10,515,506 | 0.23% |
| Rock Springs Capital Management LP | 652,400 | $6,739,292 | 0.18% |
| Point72 Asset Management, L.P. | 2,929,903 | $30,265,898 | 0.09% |
| ALGERT GLOBAL LLC | 117,327 | $1,212 | 0.06% |
| Campbell & CO Investment Adviser LLC | 45,380 | $468,775 | 0.06% |